• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评价神经生长因子血清水平对麻风病残疾的早期检测。

Evaluation of nerve growth factor serum level for early detection of leprosy disability.

机构信息

Department of Dermatology and Venereology, Faculty of Medicine, Brawijaya University, Malang 65145, East Java, Indonesia.

Department of Dermatology and Venereology, Faculty of Medicine, University of Indonesia, Depok 16424, West Java, Indonesia.

出版信息

Pan Afr Med J. 2020 Oct 13;37:145. doi: 10.11604/pamj.2020.37.145.15213. eCollection 2020.

DOI:10.11604/pamj.2020.37.145.15213
PMID:33425178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7757272/
Abstract

INTRODUCTION

this research aimed to analyze nerve growth factor (NGF) contents as diagnostic tools for early disability in leprosy patients and the cut-off point value.

METHODS

research samples consisted of 79 leprosy patients with disability grade 0 or 1 who met the clinically approved inclusion criteria. The age of patients ranged from 14 to 50 years. For both sample groups, blood serum was collected to determine NGF concentration. NGF level was analyzed by enzyme-linked immunosorbent assay (ELISA) according to the manual guide of the kit insert from Cussabio®. Statistical analysis used SPSS 17 software for Windows. A comparison was performed with the Student's t-test and the NGF concentration cut-off point was determined using a receiver operating characteristic (ROC) curve.

RESULTS

the research result demonstrated that NGF concentration in multibacillary leprosy with disability grade 0 was higher than in grade 1. Leprosy with disability grade 0 had an NGF content reaching 100.46 pg/mL, while those with grade 1 had a lower concentration of NGF at 30.56 pg/mL. The higher disability grade indicated a lower NGF concentration in the blood serum. Based on the ROC analysis result, the NGF cut-off was shown to be 81.43 pg/mL. This result indicated that low NGF in nerve and skin lesions of leprosy patients contributes to early peripheral nerve malfunction due to Mycobacterium leprae infection.

CONCLUSION

these results prove that NGF can be used as a marker of early disability in leprosy, with the cut-off value at 81.43 pg/mL.

摘要

简介

本研究旨在分析神经生长因子(NGF)含量作为麻风病患者早期残疾的诊断工具及其截断值。

方法

研究样本包括 79 名残疾等级为 0 或 1 的麻风病患者,符合临床批准的纳入标准。患者年龄在 14 至 50 岁之间。对两组样本均采集血清,以确定 NGF 浓度。NGF 水平通过酶联免疫吸附试验(ELISA)分析,试剂盒采用 Cussabio®的说明书进行操作。统计分析使用 Windows 版 SPSS 17 软件。采用学生 t 检验进行比较,并使用受试者工作特征(ROC)曲线确定 NGF 浓度截断值。

结果

研究结果表明,具有残疾等级 0 的多菌型麻风病患者的 NGF 浓度高于等级 1。具有残疾等级 0 的麻风病患者的 NGF 含量达到 100.46pg/mL,而具有等级 1 的患者的 NGF 浓度较低,为 30.56pg/mL。残疾等级越高,血清中的 NGF 浓度越低。根据 ROC 分析结果,NGF 的截断值为 81.43pg/mL。这一结果表明,麻风病患者神经和皮肤损伤中 NGF 含量降低,导致麻风分枝杆菌感染引起的早期外周神经功能障碍。

结论

这些结果证明,NGF 可作为麻风病早期残疾的标志物,截断值为 81.43pg/mL。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a853/7757272/c0752ae3c24f/PAMJ-37-145-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a853/7757272/c0752ae3c24f/PAMJ-37-145-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a853/7757272/c0752ae3c24f/PAMJ-37-145-g001.jpg

相似文献

1
Evaluation of nerve growth factor serum level for early detection of leprosy disability.评价神经生长因子血清水平对麻风病残疾的早期检测。
Pan Afr Med J. 2020 Oct 13;37:145. doi: 10.11604/pamj.2020.37.145.15213. eCollection 2020.
2
In leprosy the presence of mycobacteria in the nerve is an essential factor in the cycle and spectrum of Mycobacterium leprae infection.在麻风病中,神经中存在分枝杆菌是麻风分枝杆菌感染周期和谱系中的一个重要因素。
Lepr Rev. 1993 Jun;64(2):104-9. doi: 10.5935/0305-7518.19930012.
3
Correlation between nerve growth factor and tissue expression of IL-17 in leprosy.麻风病中神经生长因子与IL-17组织表达之间的相关性。
Microb Pathog. 2016 Jan;90:64-8. doi: 10.1016/j.micpath.2015.11.019. Epub 2015 Nov 23.
4
Nerve conduction studies in paucibacillary and multibacillary leprosy: a comparative evaluation.少菌型和多菌型麻风病的神经传导研究:一项比较评估
Indian J Lepr. 2011 Jan-Mar;83(1):15-22.
5
Evaluation of Myelin Sheath Marker Krox-20 for Detection of Early Disability in Leprosy.用于检测麻风病早期残疾的髓鞘标记物Krox-20的评估
Indian J Lepr. 2016 Apr;88(2):105-110.
6
-Specific Antibodies in Multibacillary Leprosy Patients Decrease During and After Treatment With Either the Regular 12 Doses Multidrug Therapy (MDT) or the Uniform 6 Doses MDT.多菌型麻风病患者在接受常规 12 剂量联合化疗(MDT)或统一 6 剂量 MDT 治疗期间和治疗后,特异性抗体减少。
Front Immunol. 2018 May 14;9:915. doi: 10.3389/fimmu.2018.00915. eCollection 2018.
7
Brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) blood levels in patients with acute carbon monoxide poisoning - a preliminary observations.急性一氧化碳中毒患者血液中脑源性神经营养因子(BDNF)和神经生长因子(NGF)水平——初步观察
Przegl Lek. 2016;73(8):552-9.
8
The effect of corticosteroids usage on bacterial killing, clearance and nerve damage in leprosy; part 3--Study of two comparable groups of 100 multibacillary (MB) patients each, treated with MDT + steroids vs. MDT alone, assessed at 6 months post-release from 12 months MDT.皮质类固醇使用对麻风病细菌杀灭、清除及神经损伤的影响;第3部分——对两组各100例多菌型(MB)患者的研究,一组接受多药联合化疗(MDT)+类固醇治疗,另一组仅接受MDT治疗,在完成12个月MDT停药6个月后进行评估。
Lepr Rev. 2010 Mar;81(1):41-58.
9
Comparative evaluation of antibody detection tests to facilitate the diagnosis of multibacillary leprosy.用于促进多菌型麻风病诊断的抗体检测试验的比较评估。
Appl Microbiol Biotechnol. 2016 Apr;100(7):3267-75. doi: 10.1007/s00253-016-7328-8. Epub 2016 Jan 28.
10
[Neurological manifestations of leprosy].[麻风病的神经表现]
Rev Neurol (Paris). 2003 Nov;159(11):979-95.

本文引用的文献

1
Nerve Growth Factor and Pathogenesis of Leprosy: Review and Update.神经生长因子与麻风病发病机制:综述与更新。
Front Immunol. 2018 May 7;9:939. doi: 10.3389/fimmu.2018.00939. eCollection 2018.
2
Anti-nerve growth factor in pain management: current evidence.抗神经生长因子在疼痛管理中的应用:当前证据
J Pain Res. 2016 Jun 8;9:373-83. doi: 10.2147/JPR.S89061. eCollection 2016.
3
The nerve growth factor signaling and its potential as therapeutic target for glaucoma.神经生长因子信号传导及其作为青光眼治疗靶点的潜力。
Biomed Res Int. 2014;2014:759473. doi: 10.1155/2014/759473. Epub 2014 Aug 31.
4
Nerve growth factor: from the early discoveries to the potential clinical use.神经生长因子:从早期发现到潜在的临床应用。
J Transl Med. 2012 Nov 29;10:239. doi: 10.1186/1479-5876-10-239.
5
Leprosy patients: neurotrophic factors and axonal markers in skin lesions.麻风病患者:皮肤病变中的神经营养因子和轴突标志物
Arq Neuropsiquiatr. 2012 Apr;70(4):281-6. doi: 10.1590/s0004-282x2012000400012.
6
Cytokines in rotator cuff degeneration and repair.细胞因子在肩袖退变及修复中的作用。
J Shoulder Elbow Surg. 2012 Feb;21(2):218-27. doi: 10.1016/j.jse.2011.09.020.
7
Mouse schwann cells need both NRG1 and cyclic AMP to myelinate.施万细胞需要 NRG1 和环 AMP 来髓鞘化。
Glia. 2011 May;59(5):720-33. doi: 10.1002/glia.21144. Epub 2011 Feb 14.
8
[Predictive factors of disability in patients with leprosy].[麻风病患者残疾的预测因素]
Rev Saude Publica. 2009 Apr;43(2):267-74. doi: 10.1590/s0034-89102009000200007.
9
c-Jun is a negative regulator of myelination.c-Jun是髓鞘形成的负调节因子。
J Cell Biol. 2008 May 19;181(4):625-37. doi: 10.1083/jcb.200803013.
10
An immunohistochemical, clinical and electroneuromyographic correlative study of the neural markers in the neuritic form of leprosy.麻风神经炎型神经标志物的免疫组织化学、临床及神经肌电图相关性研究
Braz J Med Biol Res. 2006 Aug;39(8):1071-81. doi: 10.1590/s0100-879x2006000800010.